Lunac Therapeutics

Leeds, England, United Kingdom

https://www.lunactherapeutics.com

Company profile

Lunac Therapeutics company profile

Epidarex Capital invests in early-stage, high growth life science and health technology Epidarex Capital is a transatlantic venture fund that invests in early-stage, high growth life science and health technology companies in under-ventured markets.

Business identity

Website: https://www.lunactherapeutics.com
Operating status: Active
Company type: For Profit
Employee range: 1-10 employees
Revenue range: $0-$1M
Founded: 2018-04-18

LinkedIn X

Headquarters

Headquarters: Leeds, England, United Kingdom
Country code: GB
Continent: Europe

Capital profile

Funding and company signals

Funding rounds: 3
Total equity funding: $10.1M
Last funding: Series Unknown / $6.7M / 2021-05-17
Last equity funding: Series Unknown / $6.7M
Investors: 5
Lead investors: 3
Founders: 2
Articles: 3

Categories and groups

Biotechnology Therapeutics Biotechnology Health Care Science and Engineering

Founders and investors

Founders

Helen PhilippouRichard Foster

Lead investors

Epidarex CapitalInnovate UKUniversity of Leeds

Investors

Caribou PropertyEpidarex CapitalInnovate UKNorthern Powerhouse Investment FundUniversity of Leeds